Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma bikunin: half-life and tissue uptake.

Aneta Kaczmarczyk1, Anna M Blom, James Alston-Smith

  • 1Department of Medical Biochemistry and Microbiology Uppsala University, Biomedical Center, Uppsala, Sweden.

Molecular and Cellular Biochemistry
|May 11, 2005
PubMed
Summary

Bikunin is a plasma protein containing chondroitin sulfate, synthesized in the liver. Despite known in vitro activities, its biological role remains unclear. This study investigated the in vivo dynamics of bikunin in rodents. Researchers measured the half-life of plasma bikunin after hepatectomy and found it to be 7 ± 2 minutes. Radiolabeled experiments showed that the chondroitin sulfate chain had little effect on elimination. Tissue uptake studies revealed that 49% of the injected radioactivity was in the kidneys at 60 minutes. The liver, bones, skin, intestine, and skeletal muscle retained 6–11% of the protein. Further experiments indicated that bikunin is first trapped extracellularly in the liver before being internalized by cells. These findings suggest a potential role for the liver in the clearance and processing of bikunin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malondialdehyde epitopes exposed on dying cells are potent modulators of complement activity and efferocytosis.

Journal of lipid research·2026
Same author

Type 2 and type 1 diabetes have opposing effects on the systemic murine complement alternative pathway.

iScience·2026
Same author

C4BP occludes the non-opsonic interaction of <i>Neisseria gonorrhoeae</i> with human neutrophil CEACAMs.

Infection and immunity·2026
Same author

COMP-PMEPA1 axis promotes epithelial-to-mesenchymal transition in breast cancer cells.

Molecular oncology·2026
Same author

C4BP occludes the non-opsonic interaction of <i>Neisseria gonorrhoeae</i> with human neutrophil CEACAMs.

bioRxiv : the preprint server for biology·2026
Same author

Nuclear cell-free DNA on the loose: an early warning signal of ischemia-reperfusion injury in kidney transplantation.

Frontiers in immunology·2026

Area of Science:

  • Plasma protein metabolism
  • Protease inhibition mechanisms
  • Biomarker dynamics in rodents

Background:

The biological function of bikunin remains unclear despite its known protease-inhibitory properties. Prior research has shown that bikunin is a plasma protein containing chondroitin sulfate, synthesized in the liver. However, the in vivo dynamics of this protein have not been fully characterized. Established knowledge includes its structural features and in vitro activities, but no prior work had resolved its clearance rate or tissue distribution. That uncertainty drove this study to investigate the half-life and tissue uptake of bikunin in rodents. This gap motivated the use of radiolabeled techniques to track its elimination and localization. No prior work had resolved the extracellular trapping of bikunin in the liver before cellular internalization. This gap motivated the use of collagenase perfusion to explore hepatic uptake mechanisms. This gap motivated the use of residualizing agents to measure tissue-specific accumulation.

Purpose Of The Study:

The aim of this study was to determine the plasma half-life and tissue distribution of bikunin in rats and mice. The specific problem addressed was the lack of data on how quickly bikunin is cleared from the bloodstream and which tissues take it up. The motivation for this investigation was to clarify the biological role of bikunin by examining its in vivo behavior. This study sought to measure the elimination rate of bikunin after hepatectomy. The study also aimed to assess the role of the chondroitin sulfate chain in its clearance. The researchers wanted to determine if the polysaccharide influenced the elimination rate of the protein. The purpose was to identify which tissues accumulate bikunin after intravenous injection. The goal was to investigate whether bikunin is first trapped extracellularly in the liver before being internalized.

Keywords:
plasma protein dynamicsbikunin clearancetissue uptake mechanismsliver protein processing

Frequently Asked Questions

The half-life of plasma bikunin was measured at 7 ± 2 minutes after hepatectomy.

The chondroitin sulfate chain had little influence on the elimination rate of the protein.

The kidneys showed 49% radioactivity uptake at 60 minutes post-injection.

Collagenase perfusion and dispersion of liver cells were used to analyze uptake.

Bikunin is first trapped extracellularly within the liver before being internalized.

Related Experiment Videos

Main Methods:

The researchers used hepatectomy to measure the half-life of plasma bikunin in rodents. Radiolabeled bikunin was injected intravenously to track its clearance. The effect of the chondroitin sulfate chain on elimination was tested by comparing labeled and unlabeled versions. Tissue uptake was studied using 125I-tyramine cellobiose as a residualizing agent. Animals were sacrificed at 60 minutes post-injection to assess organ accumulation. Liver uptake was analyzed using collagenase perfusion to isolate liver cells. The extracellular trapping of bikunin was confirmed by measuring its localization before cellular internalization. The study combined radiolabeling with perfusion techniques to dissect the uptake pathway.

Main Results:

The half-life of plasma bikunin was measured at 7 ± 2 minutes after hepatectomy. Radiolabeled bikunin showed a rapid decline in plasma levels following liver removal. The chondroitin sulfate chain had little influence on the elimination rate of the protein. Tissue uptake studies revealed 49% of radioactivity in the kidneys at 60 minutes post-injection. The liver, bones, skin, intestine, and skeletal muscle retained 6–11% of the injected radioactivity. Liver uptake was further analyzed using collagenase perfusion of the organ. These experiments showed that bikunin is first trapped extracellularly in the liver. The protein was internalized by liver cells after initial extracellular localization.

Conclusions:

The study found that plasma bikunin has a short half-life of 7 ± 2 minutes in rodents. The chondroitin sulfate chain does not significantly affect the elimination rate of the protein. The kidneys were identified as the primary site of bikunin accumulation at 60 minutes post-injection. The liver, bones, skin, intestine, and skeletal muscle also showed moderate uptake of the protein. The extracellular trapping of bikunin in the liver precedes its internalization by cells. These findings suggest a potential role for the liver in the clearance and processing of bikunin. The rapid plasma clearance indicates a dynamic turnover of the protein in vivo. The results provide insights into the in vivo dynamics of a plasma protein with unknown biological function.

The rapid clearance suggests dynamic turnover of the protein in vivo.